Improvement of surgical results for pancreatic cancer

Neoptolemos, 2010, Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial, JAMA, 304, 1073, 10.1001/jama.2010.1275

Oettle, 2007, Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial, JAMA, 297, 267, 10.1001/jama.297.3.267

Hartwig, 2011, Pancreatic cancer surgery in the new millennium: better prediction of outcome, Ann Surg, 254, 311, 10.1097/SLA.0b013e31821fd334

Mayo, 2012, Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent, Cancer, 118, 2674, 10.1002/cncr.26553

Konstantinidis, 2013, Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection?, Ann Surg, 257, 731, 10.1097/SLA.0b013e318263da2f

Vincent, 2011, Pancreatic cancer, Lancet, 378, 607, 10.1016/S0140-6736(10)62307-0

Tempero, 2012, Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN guidelines, J Natl Compr Canc Netw, 10, 703, 10.6004/jnccn.2012.0073

Imamura, 2004, A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer, Surgery, 136, 1003, 10.1016/j.surg.2004.04.030

Lygidakis, 2004, Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion. A prospective randomized study, Hepatogastroenterology, 51, 427

Callery, 2009, Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement, Ann Surg Oncol, 16, 1727, 10.1245/s10434-009-0408-6

Hartwig, 2009, Preoperative tissue diagnosis for tumours of the pancreas, Br J Surg, 96, 5, 10.1002/bjs.6407

Canto, 2012, Frequent detection of pancreatic lesions in asymptomatic high-risk individuals, Gastroenterology, 142, 796, 10.1053/j.gastro.2012.01.005

Wasif, 2010, Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes, Cancer, 116, 3369, 10.1002/cncr.25070

Tanaka, 2012, International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas, Pancreatology, 12, 183, 10.1016/j.pan.2012.04.004

Rodriguez, 2007, Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection, Gastroenterology, 133, 72, 10.1053/j.gastro.2007.05.010

Maguchi, 2011, Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan, Pancreas, 40, 364, 10.1097/MPA.0b013e31820a5975

Fritz, 2012, Small (Sendai negative) branch-duct IPMNs: not harmless, Ann Surg, 256, 313, 10.1097/SLA.0b013e31825d355f

Correa-Gallego, 2010, Incidental pancreatic cysts: do we really know what we are watching?, Pancreatology, 10, 144, 10.1159/000243733

Salvia, 2012, Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality, Surgery, 152, S135, 10.1016/j.surg.2012.05.019

Uehara, 2008, Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas, Gut, 57, 1561, 10.1136/gut.2007.145631

Bilimoria, 2007, National failure to operate on early stage pancreatic cancer, Ann Surg, 246, 173, 10.1097/SLA.0b013e3180691579

Mann, 2010, A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery, HPB (Oxford), 12, 380, 10.1111/j.1477-2574.2010.00179.x

Bassi, 2005, Postoperative pancreatic fistula: an international study group (ISGPF) definition, Surgery, 138, 8, 10.1016/j.surg.2005.05.001

Xiong, 2012, Systematic review and meta-analysis of outcomes after intraoperative pancreatic duct stent placement during pancreaticoduodenectomy, Br J Surg, 99, 1050, 10.1002/bjs.8788

Motoi, 2012, Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy, Br J Surg, 99, 524, 10.1002/bjs.8654

Topal, 2013, Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial, Lancet Oncol, 14, 655, 10.1016/S1470-2045(13)70126-8

Diener, 2011, Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial, Lancet, 377, 1514, 10.1016/S0140-6736(11)60237-7

Carter, 2013, A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes?, J Gastrointest Surg, 17, 102, 10.1007/s11605-012-1963-x

Olah, 2009, Randomized clinical trial of techniques for closure of the pancreatic remnant following distal pancreatectomy, Br J Surg, 96, 602, 10.1002/bjs.6620

Frozanpor, 2012, The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial, Ann Surg, 255, 1032, 10.1097/SLA.0b013e318251610f

Gurusamy, 2012, Somatostatin analogues for pancreatic surgery, Cochrane Database Syst Rev, 6, 10.1002/14651858.CD008370.pub2

Gans, 2012, Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula, Br J Surg, 99, 754, 10.1002/bjs.8709

Diener, 2011, Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma, Cochrane Database Syst Rev, 5

Kawai, 2011, Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy, Ann Surg, 253, 495, 10.1097/SLA.0b013e31820d98f1

Tani, 2006, Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial, Ann Surg, 243, 316, 10.1097/01.sla.0000201479.84934.ca

van der Gaag, 2010, Preoperative biliary drainage for cancer of the head of the pancreas, N Engl J Med, 362, 129, 10.1056/NEJMoa0903230

Eshuis, 2010, Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage, Ann Surg, 252, 840, 10.1097/SLA.0b013e3181fd36a2

Fang, 2012, Pre-operative biliary drainage for obstructive jaundice, Cochrane Database Syst Rev, 9

Venkat, 2012, Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis, Ann Surg, 255, 1048, 10.1097/SLA.0b013e318251ee09

Kooby, 2010, A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?, J Am Coll Surg, 210, 779, 10.1016/j.jamcollsurg.2009.12.033

Kendrick, 2010, Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience, Arch Surg, 145, 19, 10.1001/archsurg.2009.243

Joseph, 2009, Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection, J Am Coll Surg, 208, 520, 10.1016/j.jamcollsurg.2009.01.019

Ghaferi, 2009, Variation in hospital mortality associated with inpatient surgery, N Engl J Med, 361, 1368, 10.1056/NEJMsa0903048

Büchler, 2003, Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy, Arch Surg, 138, 1310, 10.1001/archsurg.138.12.1310

Birkmeyer, 2002, Hospital volume and surgical mortality in the United States, N Engl J Med, 346, 1128, 10.1056/NEJMsa012337

Birkmeyer, 2007, Hospital volume and late survival after cancer surgery, Ann Surg, 245, 777, 10.1097/01.sla.0000252402.33814.dd

Gooiker, 2011, Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery, Br J Surg, 98, 485, 10.1002/bjs.7413

Birkmeyer, 2003, Surgeon volume and operative mortality in the United States, N Engl J Med, 349, 2117, 10.1056/NEJMsa035205

Bilimoria, 2007, Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume, Cancer, 110, 1227, 10.1002/cncr.22916

Finks, 2011, Trends in hospital volume and operative mortality for high-risk surgery, N Engl J Med, 364, 2128, 10.1056/NEJMsa1010705

Lemmens, 2011, Improving outcome for patients with pancreatic cancer through centralization, Br J Surg, 98, 1455, 10.1002/bjs.7581

Butturini, 2008, Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials, Arch Surg, 143, 75, 10.1001/archsurg.2007.17

Brennan, 2004, Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas, Ann Surg, 240, 293, 10.1097/01.sla.0000133125.85489.07

Isaji, 2004, Classification of pancreatic cancer: comparison of Japanese and UICC classifications, Pancreas, 28, 231, 10.1097/00006676-200404000-00003

Bilimoria, 2007, Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database, Cancer, 110, 738, 10.1002/cncr.22852

Wasif, 2010, Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes, Cancer, 116, 3369, 10.1002/cncr.25070

Gillen, 2010, Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages, PLoS Med, 7, e1000267, 10.1371/journal.pmed.1000267

Chua, 2010, Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review, J Gastrointest Surg, 14, 1442, 10.1007/s11605-009-1129-7

Zhou, 2012, Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis, World J Surg, 36, 884, 10.1007/s00268-012-1461-z

Slidell, 2008, Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis, Ann Surg Oncol, 15, 165, 10.1245/s10434-007-9587-1

Iqbal, 2009, A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1909 patients, Eur J Surg Oncol, 35, 79, 10.1016/j.ejso.2008.01.002

Jamieson, 2010, Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma, Ann Surg, 251, 1003, 10.1097/SLA.0b013e3181d77369

Sanjay, 2012, ‘Artery-first’ approaches to pancreatoduodenectomy, Br J Surg, 99, 1027, 10.1002/bjs.8763

Hackert, 2010, Uncinate process first—a novel approach for pancreatic head resection, Langenbecks Arch Surg, 395, 1161, 10.1007/s00423-010-0663-9

Pessaux, 2009, Preliminary experience with the hanging maneuver for pancreaticoduodenectomy, Eur J Surg Oncol, 35, 1006, 10.1016/j.ejso.2009.04.009

Reddy, 2009, Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival, Ann Surg, 250, 282, 10.1097/SLA.0b013e3181ae9f93

Billings, 2005, Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?, J Gastrointest Surg, 9, 1059, 10.1016/j.gassur.2005.05.014

Schmidt, 2007, Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma, Surgery, 142, 572, 10.1016/j.surg.2007.07.016

Mollberg, 2011, Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis, Ann Surg, 254, 882, 10.1097/SLA.0b013e31823ac299

Hartwig, 2009, Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome, Ann Surg, 250, 81, 10.1097/SLA.0b013e3181ad657b

Burdelski, 2011, Multivisceral resections in pancreatic cancer: identification of risk factors, World J Surg, 35, 2756, 10.1007/s00268-011-1263-8

Neoptolemos, 2001, Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial, Lancet, 358, 1576, 10.1016/S0140-6736(01)06651-X

Neoptolemos, 2009, Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials, Br J Cancer, 100, 246, 10.1038/sj.bjc.6604838

Ueno, 2009, A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer, Br J Cancer, 101, 908, 10.1038/sj.bjc.6605256

Neuhaus, 2008, CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC), Proc Am Soc Clin Oncol, 26

Neoptolemos, 2012, Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial, JAMA, 308, 147, 10.1001/jama.2012.7352

Stocken, 2005, Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer, Br J Cancer, 92, 1372, 10.1038/sj.bjc.6602513

Chauffert, 2008, Ann Oncol, 19, 1592, 10.1093/annonc/mdn281

Schmidt, 2012, Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma, J Clin Oncol, 30, 4077, 10.1200/JCO.2011.38.2960

Strobel, 2013, Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival, Ann Surg Oncol, 20, 964, 10.1245/s10434-012-2762-z